Literature DB >> 7834625

Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk.

M J Blaser1, P H Chyou, A Nomura.   

Abstract

Helicobacter pylori is an important risk factor for gastric cancer, gastric ulcer, and duodenal ulcer, yet most infected persons do not develop disease. We examined two correlates of acquisition age, sibship size and birth order, to evaluate the hypothesis that early life acquisition of H. pylori is a risk factor for the development of these illnesses. In earlier nested case-control studies of a cohort of Japanese American men in Hawaii, evidence of H. pylori infection was associated with the development of gastric cancer or gastric or duodenal ulceration during the subsequent period, 1968-1989. The present analysis included 102, 147, and 64 men who developed adenocarcinoma of the distal stomach, gastric ulcer, and duodenal ulcer, respectively, and a matched control for each. Sibship size and birth order data were analyzed as risk factors for development of these diseases. H. pylori-infected but not H. pylori-uninfected men from larger sibships (odds ratio, 2.06) and of higher birth order (odds ratio, 1.67) were at increased risk for developing gastric cancer. H. pylori- infected men but not uninfected men at higher birth order had increased risk of gastric (odds ratio, 1.64) but not duodenal ulcers. These data are consistent with the hypothesis that early life acquisition of H. pylori increases the risk of developing both gastric cancer and gastric ulcer but not duodenal ulcer.

Entities:  

Mesh:

Year:  1995        PMID: 7834625

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  108 in total

1.  Detection of Helicobacter pylori in stool specimens by non-invasive antigen enzyme immunoassay in children: multicentre Italian study.

Authors:  G Oderda; A Rapa; B Ronchi; P Lerro; M Pastore; A Staiano; G L de'Angelis; P Strisciuglio
Journal:  BMJ       Date:  2000-02-05

2.  Helicobacter pylori infection.

Authors:  Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

3.  Sequential Therapy for Helicobacter Pylori Eradication: The Time is Now!

Authors:  Dino Vaira; Angelo Zullo; Cesare Hassan; Giulia Fiorini; Nimish Vakil
Journal:  Therap Adv Gastroenterol       Date:  2009-11       Impact factor: 4.409

4.  Common immune-related exposures/conditions and risk of non-Hodgkin lymphoma: a case-control study of disease-discordant twin pairs.

Authors:  Jun Wang; Thomas M Mack; Ann S Hamilton; Amie E Hwang; Bharat N Nathwani; Kamil Masood; Laura H Buchanan; Leslie Bernstein; Dennis M Deapen; Otoniel Martínez-Maza; Wendy Cozen
Journal:  Am J Epidemiol       Date:  2015-08-12       Impact factor: 4.897

5.  Myeloperoxidase, xanthine oxidase and superoxide dismutase in the gastric mucosa of Helicobacter pylori positive and negative pediatric patients.

Authors:  Mustafa Akcam; Oguz Elmas; Aygen Yilmaz; Serkan Cağlar; Reha Artan; Tekinalp Gelen; Yakup Alicigüzel
Journal:  Mol Cell Biochem       Date:  2006-06-07       Impact factor: 3.396

6.  Childhood allergies, birth order and family size.

Authors:  P Cullinan
Journal:  Thorax       Date:  2006-01       Impact factor: 9.139

7.  iceA genotypes of Helicobacter pylori strains isolated from Brazilian children and adults.

Authors:  A A Ashour; G B Collares; E N Mendes; V R de Gusmão; D M Queiroz; P P Magalhães; A S de Carvalho; C A de Oliveira; A M Nogueira; G A Rocha; A M Rocha
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

8.  Long-term use of nonsteroidal anti-inflammatory drugs normalizes the kinetics of gastric epithelial cells in patients with Helicobacter pylori infection via attenuation of gastric mucosal inflammation.

Authors:  Tetsuya Tanigawa; Toshio Watanabe; Kazuhide Higuchi; Kazunari Tominaga; Yasuhiro Fujiwara; Nobuhide Oshitani; Andrzej S Tarnawski; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

9.  Clinical significance of Helicobacter pylori seropositivity and seronegativity in asymptomatic blood donors.

Authors:  M Menegatti; J Holton; N Figura; G Biasco; C Ricci; G Oderda; R Conte; M Miglioli; D Vaira
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

10.  Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis.

Authors:  Yoshihisa Urita; Kazuo Hike; Naotaka Torii; Yoshinori Kikuchi; Eiko Kanda; Masahiko Sasajima; Kazumasa Miki
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.